Many testicular cancers contain both seminoma and non-seminoma cells. These mixed germ cell tumors are treated as non-seminomas. In this stage, the cancer has not spread outside the testicle, and your Because seminoma cells are very sensitive to radiation, low doses can. Patients with Stage 1 testicular cancer of non-seminoma type have a primary cancer that is limited to the testes and is curable in more than 95% of cases.

Author: Shakagor Gokasa
Country: Guadeloupe
Language: English (Spanish)
Genre: Relationship
Published (Last): 22 March 2017
Pages: 432
PDF File Size: 5.81 Mb
ePub File Size: 18.84 Mb
ISBN: 809-5-63839-979-9
Downloads: 79233
Price: Free* [*Free Regsitration Required]
Uploader: Nigis

It is clear, however, that the differences will be small and hard to detect without an extremely large clinical trial performing a direct comparison of the 3 approaches. C Coppin Fraser Valley Cancer Centre, Vancouver, British Columbia and their colleagues see below for kindly providing their data for the analyses in this paper.

Furthermore, survival estimates for infrequent teticular of risk factors are not reliable and therefore provide little information on the prognosis of patients with these risk factors.

All patients were treated between and with cisplatin-based chemotherapy. What is Testicular Cancer? Yolk sac carcinomas respond very well to chemotherapyeven if they have spread.

Patients who are interested in participating in a clinical trial should discuss the sfminomatoso and benefits of clinical trials with their physician.

Testicular cancer: MedlinePlus Medical Encyclopedia

We therefore examined whether discriminative ability increased within the poor prognosis group of each classification. Prognostic modelling with logistic regression analysis: Recurrences usually occur within 18 months of surgery and most patients are subsequently cured with combination chemotherapy.


However, there are two main types of tumors that account for the majority of testicular cancers:. Classification 5R and classification 5Ri are very flexible with many possible cutoff points. Use the map below to search for Texas Oncology centers close by.

Types of testicular cancer

The major advantage of retroperitoneal node dissection is accuracy of staging. If these tests do not find any signs that cancer has spread beyond the testicle, no other treatment is needed.

S Werner Hansen Rigshospitalet, Copenhagen. Testicular cancer treatment PDQ — health professional version. Treatment may not be needed as long as there are no signs that the CIS is growing or turning into an invasive cancer.

In Table 1how the risk factors were combined into three prognostic groups for patients with nonseminomatous germ cell tumours NSGCT with either good, intermediate or poor prognosis are shown.

Treatment depends on your tumor marker levels after surgery and the extent of spread to the retroperitoneal lymph nodes. This is a very rare and fast-growing type of testicular cancer in adults. Sometimes CIS is found incidentally by accident when a testicular biopsy is done for another reason, such as infertility.

Testicular Cancer Types: Seminoma/Non-Seminoma | CTCA

This fluid then enters the urethra, the tube in the center of the penis through which both urine and semen leave the body. We calculated the estimated 5-year survival rate for each score.

This exam is called transillumination. Donate to Cancer Research. Testicular germ cell tumours seminomatous and nonseminomatous are the most common cancers among smeinomatoso adult men.

It appears that the maximum discriminative ability might have been reached with the current IGCC risk factors and coding, making further improvement in discriminative ability difficult. Testicular non seminomatous germ cell tumor describes a group of testicular germ cell tumors see this term occurring in the third decade of life mean age: We did, however, find that not all intermediate tumour markers and poor risk factors were equally important, and that taking these differences into account does affect the classification of patients.


This, in combination with the poorer performance, suggests that recursive partitioning is less suitable for the construction of prognostic classifications.

The lack of improvement in discriminative ability in both the classifications with three and testiclar groups might also be explained by the dominance of the good prognosis group, which has a similar survival for all classifications and contains more than half of all patients.

A sum score based on a regression model with interactions is, however, more difficult to calculate and interpret. If it looks as if cancer has recurred in a lot of the retroperitoneal lymph nodes or if the cancer has returned elsewhere, chemo is usually recommended.

On the other hand, high-risk patients, eligible for more intensive treatment, for example, stem-cell support or high-dose chemotherapy, should be identified Bokemeyer et al nl, ,